Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value
Keywords:colorectal cancer, Tertiary Lymphoid Structures, tumor stroma
Introduction: Tumor-infiltrating lymphocytes (TIL) in tumor stroma are considered to be involved in elimination of malignant cells and in prevention of metastasis formation. TIL are consisted of T lymphocytes including cytotoxic lymphocytes that are a constituent part of the effector mechanism of anti-tumor immunity and B lymphocytes that can form tertiary lymphoid structures (TLS). TLS have been described in several solid tumors and in colorectal carcinoma (CRC) and they influence on the local and systemic anti-cancer response.
The aim of this study was to quantify the presence of TLS in CRC patients and to determine their role in tumor progression.
Patients and methods: The study included 103 patients with CRC who underwent surgery at the University Clinic of Digestive Surgery in Skopje, whose operative material was analyzed at the Institute of Pathology, Medical Faculty in Skopje. The density of TLS was determined and correlated with neoplasm status of local growth (T), positive lymph nodes, lymphatic invasion, stage of the disease and tumor grade.
Results: The density of TLS was significantly higher in patients with higher stage, lower T status, negative lymph nodes, in patients with no lymphatic invasion and with better differentiated tumors.
Conclusion: The density of TLS plays an important role in controlling the tumor growth and it can be a parameter for neoplasm progression in CRC patients. The density of TLS has influence on the control of tumor progression.
Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin Jr EW, de la Chapelle A, Frankel WL. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene. 2004; 23:366 77. https://doi.org/10.1038/sj.onc.1208013 PMid:15326482
Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999; 59:5002-11. PMid:10519415
Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010; 29(8):1093. https://doi.org/10.1038/onc.2009.416 PMid:19946335
Di Caro G, Marchesi F, Laghi L, Grizzi F. Immune cells: plastic players along colorectal cancer progression. Journal of cellular and molecular medicine. 2013; 17(9):1088-95. https://doi.org/10.1111/jcmm.12117 PMid:24151976 PMCid:PMC4118167
Bergomas F, Grizzi F, Doni A, Pesce S, Laghi L, Allavena P, Mantovani A, Marchesi F. Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer. Cancers (Basel). 2012; 4(1):1â€“10. https://doi.org/10.3390/cancers4010001 PMid:24213222 PMCid:PMC3712686
Deschoolmeester V, Baay M, Lardon F, Pauwels P, Peeters M. Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. Cancer Microenvironment. 2011; 4:377â€“392. https://doi.org/10.1007/s12307-011-0068-5 PMid:21618031 PMCid:PMC3234325
SautÃ¨s-Fridman C, Lawand M, Giraldo NA, Kaplon H, Germain C, Fridman WH, Dieu-Nosjean MC. Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention. Front Immunol. 2016; 7:407. eCollection 2016.
de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell. 2005; 7:411-423. https://doi.org/10.1016/j.ccr.2005.04.014 PMid:15894262
Trajkovski G, Ognjenovic LJ, Jota G, Hadzi-Manchev D, Trajkovska V, Volcevski G, Nikolova D, Petrushevska G, Janevska V, Janevski V. Tumour Lymphocytic Infiltration, Its Structure and Influence in Colorectal Cancer Progression. Open Access Maced J Med Sci. 2018; 6(6):1003â€“1009. https://doi.org/10.3889/oamjms.2018.279 PMid:29983792 PMCid:PMC6026406
Amin MB. Editor-in-Chief. AJCC cancer staging manual, 8th ed. Switzerland: Springer, 2017. https://doi.org/10.1007/978-3-319-40618-3
Nichols J, Dozois R. Section IV: Colon and Retum: Naoplasma in Surgery of the Colon&Rectum. Churchill Livingstone, 1997.
Johnson R, Marsh R, Carson J, Seymour K. A comparison of two metods of palliation of large bowel obstruction due to irremovable colon cancer. Ann R Coll Surg Engl. 1004; 86:99-103. https://doi.org/10.1308/003588404322827473 PMid:15005927 PMCid:PMC1964159
Roscher R, Frank R, Wagner R, Safi F, Veger HG. Surgical treatment results in colonic obstruction. Chirurg. 1991; 62(3):201-5. PMid:2036896
Rudy DR, Zdon MJ. Update on colorectal cancer. Am Fam Physician. 2000; 61(6):1759-70. PMid:10750881
O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004; 96:1420â€“5. https://doi.org/10.1093/jnci/djh275 PMid:15467030
Sobin L, Wittekind C, eds. TNM classification of malignant tumours. New York: Wiley-Liss, 2002. PMCid:PMC122590
Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nature immunology. 2002; 3(11):991. https://doi.org/10.1038/ni1102-991 PMid:12407406
Roxburgh CS, Richards CH, Macdonald AI, Powell AG, McGlynn LM, McMillan DC, Horgan PG, Edwards J, Shiels PG. The in situ local immune response, tumour senescence and proliferation in colorectal cancer. British journal of cancer. 2013; 109(8):2207. https://doi.org/10.1038/bjc.2013.556 PMid:24022192 PMCid:PMC3798960
PÐ°ges F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. New England J Med. 2005; 353:2654-2666. https://doi.org/10.1056/NEJMoa051424 PMid:16371631
Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predicts clinical outcome Science. 2006; 313:1960-1964. https://doi.org/10.1126/science.1129139 PMid:17008531
Reuschenbach M, von Knebel Doeberitz M, Wentzensen N. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother. 2009; 58(10):1535-44. https://doi.org/10.1007/s00262-009-0733-4 PMid:19562338 PMCid:PMC2782676
Coronella-Wood JA, Hersh EM. Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother. 2003; 52(12):715-38. https://doi.org/10.1007/s00262-003-0409-4 PMid:12920480
Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol. 2010; 185(9):4977-82. https://doi.org/10.4049/jimmunol.1001323 PMid:20962266
Di Caro G, Bergomas F, Grizzi F, Doni A, Bianachi P, Malesci A, Laghi L, Allavana P, Mantovani A, Marchesi F. Occurrence of tertiary lymphoid tissue is associated to T cell infiltration and predicts better prognosis in early stage colorectal cancers. Clin Cancer Res 2018; 2018:14-17.
Chew V, Toh HC, Abastado JP. Immune microenvironment in tumor progression: characteristics and challenges for therapy. Journal of oncology. 2012; 2012.
Fridman WH, Galon J, PagÃ¨s F, Tartour E, SautÃ¨s-Fridman C, Kroemer G. Prognostic and predictive impact of intra-and peritumoral immune infiltrates. Cancer research. 2011. https://doi.org/10.1158/0008-5472.CAN-11-1316
How to Cite
Copyright (c) 2018 Gjorgji Trajkovski, Ljubomir Ognjenovic, Zoran Karadzov, Gjorgji Jota, Dragan Hadzi-Manchev, Ognen Kostovski, Goce Volcevski, Vanja Trajkovska, Dafina Nikolova, Liljana Spasevska, Vesna Janevska, Vlado Janevski
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.